Product Hotline

APRIL 01, 2009

Soma 250 mg

Soma (carisoprodol) 250 mg, manufactured by Meda Pharmaceuticals Inc (Somerset, NJ), is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. The recommended dose is 250 to 350 mg 3 times a day and at bedtime. The recommended maximum duration of Soma use is up to 2 or 3 weeks.

www.soma250.com



Kapidex

Kapidex (dexlansoprazole) delayedrelease capsules, manufactured by Takeda Pharmaceuticals North America Inc (Deerfield, IL), recently received FDA approval for the once-daily oral treatment of heartburn associated with symptomatic, nonerosive gastroesophageal reflux disease, the healing of erosive esophagitis, and the maintenance of healed erosive esophagitis. The product is available in 30- and 60-mg capsules.

www.kapidex.com



Symbicort

AstraZeneca (Wilmington, DE) recently received FDA approval for Symbicort (budesonide/formoterol fumarate dihydrate) 160/4.5 mcg for the twice daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. Symbicort also is indicated for the maintenance treatment of asthma in patients 12 years and older.

www.mysymbicort.com



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.